Cargando…

人源化CD19 CAR-T细胞治疗儿童及青少年复发难治急性淋巴细胞白血病患者的疗效及安全性

OBJECTIVE: To investigate the efficacy and safety of humanized CD19-specific chimeric antigen receptor T cells(hCART19s)in treating children and young adults with relapsed/refractory acute lymphoblastic leukemia(R/R ALL)and to analyze relevant factors affecting its curative effect and prognosis. MET...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395560/
https://www.ncbi.nlm.nih.gov/pubmed/36709132
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.07.005